Plasma glucagon-like peptide-2 in cats with chronic enteropathies.

ABSTRACT:

Objectives

The objective of this study was to compare plasma glucagon-like peptide-2 (GLP-2) concentrations in cats with chronic enteropathies (CE) with those of healthy cats.

Methods

Nineteen client-owned cats with a histopathologic diagnosis of either idiopathic chronic enteropathy (CIE) or low-grade lymphoma and six healthy client-owned cats were enrolled in a prospective study between 2 December 2021 and 9 June 2023. Fasted and postprandial plasma GLP-2 concentrations were measured via ELISA in CE cats at the time gastrointestinal biopsies were obtained and before CE treatment. In cats with a histopathologic diagnosis of CIE, plasma GLP-2 concentrations were re-evaluated after 1 month of CE treatment.

Results

There was no significant difference in plasma GLP-2 con

SUBMITTER: Jugan MC 

PROVIDER: S-EPMC11755514 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature